Beryl Drugs Ltd
₹24.88▲ +1.07 (+4.49%)
BERLDRG·BSE·Healthcare
Market Cap
12.60 Cr
PE Ratio
82.93
Volume
255
Day High - Low
24.99 - 23.10
52W High-Low
27.45 - 15.92
₹24.88▲ +1.07 (+4.49%)
Market Cap12.60 Cr
PE Ratio82.93
Volume255
Day High - Low24.99 - 23.10
52W High-Low27.45 - 15.92
Beryl Drugs Ltd (BERLDRG): company summary
The company's business is shrinking, with annual revenue falling 11.0% to ₹19 crore and annual net profit turning negative at ₹0 crore.
Beryl Drugs Ltd (BERLDRG) is a micro-cap Healthcare company valued at ₹13 crore operating in Pharmaceuticals on the NSE and BSE.
- Recent price move
- Beryl Drugs Ltd last traded at ₹24.88, up 4.49% on the day.
- Recent developments
- On 2026-06-30, the company reported its latest quarter results, showing revenue increased 52.4% compared to the same quarter a year earlier, but net profit stayed at zero. Promoter holding rose by 0.34 percentage points to 27.82% as of 2026-06-30.
- Financial performance
- The company's business is shrinking, with annual revenue falling 11.0% to ₹19 crore and annual net profit turning negative at ₹0 crore. The latest quarter saw revenue rise 52.4% year-on-year to ₹7 crore, but net profit remained at ₹0 crore, matching the year-ago figure.
- Valuation multiples
- The stock trades at 82.9 times earnings, a premium to the Healthcare median of 32.0, 1.24 times book value.
- Things to watch
- The company reported an annual net profit of ₹0 crore, a decline of 27.6% from the prior year. Net profit margin narrowed to 2.3% from 2.7% the previous year. The stock is 13.3% below its 52-week high, and the latest quarter net profit did not improve despite a sharp revenue increase.
- Where it stands
- Beryl Drugs Ltd's business is shrinking, with revenue falling 11.0% annually and profit turning negative. The latest quarter saw revenue rise 52.4% year-on-year, but net profit remained at zero. The stock is 13.3% below its 52-week high, and promoter holding increased slightly to 27.82%.
Summarised by DocStoX's model on 2026-10-18 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.
DocStoX Score
4.1/10
Weak
Fair Value
Sign in to see
ROE
4.30%
Weak
P/E
82.93x
Expensive
Debt / Equity
0.25
Low
Industry
Healthcare
Pharmaceuticals
Overall View
Mixed
Price performance
Day₹23.10
₹24.99
52W₹15.92
₹27.45
DocStoX take
Supported by momentum (7.5) and risk (6.7), but held back by valuation (0.4). Momentum looks strong at 7.5, but that is offset by valuation at 0.4 and quality at 2.6. We are calling it Mixed rather than resolving the conflict for you.
DocStoX score
Low confidence4.1
/10
Weak
Quality
Weak
ROE 4.3%
Valuation
Expensive
P/E 82.9×
Growth
Slow
Revenue +6.0% 5Y CAGR
Risk
Moderate
D/E 0.25
Momentum
Strong
78% of 52-week range
At a glance
Market Cap
₹13 Cr
52W High / Low
₹27 / ₹16
Dividend Yield
0.00%
Promoter Holding
27.82%
EPS (TTM)
₹0.30
Book Value
₹19.44
Key highlights
- Low leverage — D/E 0.25
- Valuation is weak (0.4/10)
- Expensive at 83× earnings
1 Positive3 Watchouts
Growth
Financials
Technicals
Peers
News
Forecasts
About the company
More data
Filings, corporate actions and ownership detail — opened on demand.
More Healthcare stocks · Pharmaceuticals
Explore Beryl Drugs Ltd’s valuation
Free deep-dive tools · no sign-up
Fair ValueOur fair-value estimate, upside, and Bear/Base/Bull scenarios.Intrinsic ValueGraham & earnings-power intrinsic value with margin of safety.DCFDiscounted cash flow — free cash flow, growth, value per share.ValuationP/E, P/B, earnings yield and the full multiples picture.Financial RatiosProfitability, leverage and efficiency ratios at a glance.PeersHow it stacks up against its closest listed competitors.
Beryl Drugs Ltd peers in Healthcare
Other Healthcare stocks on the NSE & BSE. See the full Healthcare sector list.
Sun Pharmaceutical Industries LimitedDivi's Laboratories LimitedTorrent Pharmaceuticals LimitedLaurus Labs LimitedZydus Lifesciences LimitedApollo Hospitals Enterprise LimitedCipla LimitedDr. Reddy's Laboratories LimitedMankind Pharma LimitedAurobindo Pharma LimitedLupin LimitedManipal Health Enterprises Limited
Compare Beryl Drugs Ltd with peers
Related tools & concepts
Value Beryl Drugs Ltd with the ratios and calculators DocStoX uses in its analysis.
P/E RatioPrice to earningsReturn on Equity (ROE)ProfitabilityROCECapital efficiencyDebt to EquityLeverageP/B RatioPrice to bookNet Profit MarginBottom-line efficiencyDCF / Intrinsic ValueEstimate fair valueCAGR CalculatorAnnualised returnDividend YieldIncome on pricePosition SizeRisk-based sizingBrokerage CalculatorCharges on a tradeSIP CalculatorSystematic investing